Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             19 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Bendamustine is safe and effective for lymphodepletion before tisagenlecleucel in patients with refractory or relapsed large B-cell lymphomas Ghilardi, G.

33 9 p. 916-928
artikel
2 Bridging the implementation gap: delivering complex genomic analysis for routine cancer care Beer, P.A.

33 9 p. 857-859
artikel
3 Corrigendum to “Corrigendum to ‘Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up’” Dimopoulos, M.A.

33 9 p. 988
artikel
4 Does the result of a small-scale phase II study of nivolumab for cancer of unknown primary justify regulatory approval? Sasaki, Y.

33 9 p. 984-985
artikel
5 Editorial Board
33 9 p. iii
artikel
6 Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ☆ Oaknin, A.

33 9 p. 860-877
artikel
7 Fewer cetuximab-related skin-toxicities in colorectal cancer patients treated with encorafenib: a Yin and Yang effect of ERK paradoxical activation Ciccolini, J.

33 9 p. 981-982
artikel
8 Immunotherapy in unresectable stage III non-small-cell lung cancer: state of the art and novel therapeutic approaches Cortiula, F.

33 9 p. 893-908
artikel
9 Impact of acetaminophen on the efficacy of immunotherapy in cancer patients Bessede, A.

33 9 p. 909-915
artikel
10 In the phase III IMmotion151 trial of metastatic renal cell carcinoma the easy-to-implement modified Glasgow prognostic score predicts outcome more accurately than the IMDC score Saal, J.

33 9 p. 982-984
artikel
11 Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study Maio, M.

33 9 p. 929-938
artikel
12 Pimitespib in patients with advanced gastrointestinal stromal tumor (CHAPTER-GIST-301): a randomized, double-blind, placebo-controlled phase III trial Kurokawa, Y.

33 9 p. 959-967
artikel
13 Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study Dimitriou, F.

33 9 p. 968-980
artikel
14 Table of Contents
33 9 p. i-ii
artikel
15 The deleterious effect of acetaminophen in cancer immunotherapy Berraondo, P.

33 9 p. 855-856
artikel
16 The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline ☆ Di Maio, M.

33 9 p. 878-892
artikel
17 Validation of the Decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy – an ancillary study of the SAKK 09/10 randomized clinical trial ☆ Dal Pra, A.

33 9 p. 950-958
artikel
18 VP6-2022: Adjuvant pertuzumab and trastuzumab in patients with early HER-2 positive breast cancer in APHINITY: 8.4 years' follow-up Loibl, S.

33 9 p. 986-987
artikel
19 Whole-genome and transcriptome analysis enhances precision cancer treatment options Pleasance, E.

33 9 p. 939-949
artikel
                             19 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland